Bioventus Inc. Class A Common Stock

BVSNASDAQ • USD
14.96 USD
↘ 0.08 (0.53%)AT CLOSE (03:59 PM EDT)
14.95
↘ 0.01 (0.07%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
14.95
↘ 0.01 (0.07%)
🔴Market: CLOSED

BVS is currently priced at $14.96. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include exceptional Return on Equity (25.1%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BVS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 23, 2026.

Open?$14.94
High?$15.09
Low?$14.76
Prev. Close?$15.04
Volume?383.6K
Avg. Volume?420.8K
VWAP?$14.96
Rel. Volume?0.91x
Bid / Ask
Bid?$14.96 × 300
Ask?$15.50 × 3.0K
Spread?$0.54
Midpoint?$15.23
Valuation & Ratios
Market Cap?1.0B
Shares Out?68.3M
Float?45.8M
Float %?67.0%
P/E Ratio?17.86
P/B Ratio?4.48
EPS?$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Employees
950
Market Cap
1.0B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-02-11
Address
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM, NC 27703
Phone: (919) 474-6700
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
45
Momentum?
50
Short Sent.?
38
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.27Grey
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.91%Elevated
Short Interest?3.2M
Days to Cover?6.7
Free Float45.8M
Avg Daily Volume471.6K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.17Adequate
Cash Ratio?0.19Low
Debt/Equity?1.09Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
72
17.9CHEAP▾
P/B?
Peers
100
S&P
40
4.48FAIR▾
P/S?
Peers
100
S&P
73
1.76CHEAP▾
P/FCF?
Peers
100
S&P
86
10.8CHEAP▾
EV/EBITDA?
Peers
100
S&P
70
11.7CHEAP▾
EV/Sales?
Peers
100
S&P
73
2.13CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
74
25.1%STRONG▾
ROA?
Peers
50
S&P
68
8.5%STRONG▾
Cash Flow & Enterprise
FCF?$94.3M
Enterprise Value?$1.2B
Fundamentals ratios updated end of day